Overview
- FaceAge, a deep learning algorithm, analyzes facial photographs to estimate biological age and predict survival outcomes in cancer patients.
- The tool was validated on 6,196 cancer patients and published in The Lancet Digital Health on May 8, 2025.
- Cancer patients' biological age, as estimated by FaceAge, averaged five years older than their chronological age, correlating with worse survival outcomes.
- Clinicians using FaceAge data significantly improved their short-term life expectancy predictions for palliative radiotherapy patients.
- Researchers are expanding validation efforts to address biases and test the algorithm in broader clinical and real-world settings.